BR0211282A - Formulação farmacêutica - Google Patents

Formulação farmacêutica

Info

Publication number
BR0211282A
BR0211282A BR0211282-5A BR0211282A BR0211282A BR 0211282 A BR0211282 A BR 0211282A BR 0211282 A BR0211282 A BR 0211282A BR 0211282 A BR0211282 A BR 0211282A
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
admixture
composition
active agent
fumed silica
Prior art date
Application number
BR0211282-5A
Other languages
English (en)
Other versions
BRPI0211282B8 (pt
BR0211282B1 (pt
Inventor
Alvin Berlat
Original Assignee
Advanced Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biotechnologies filed Critical Advanced Biotechnologies
Publication of BR0211282A publication Critical patent/BR0211282A/pt
Publication of BR0211282B1 publication Critical patent/BR0211282B1/pt
Publication of BRPI0211282B8 publication Critical patent/BRPI0211282B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"FORMULAçãO FARMACêUTICA TóPICA". A presente invenção se refere a uma composição compreendendo fluido de silicone não volátil em mistura com fumos de sílica e um agente farmaceuticamente ativo.
BRPI0211282A 2001-07-24 2002-07-23 curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador BRPI0211282B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30754801P 2001-07-24 2001-07-24
PCT/GB2002/003387 WO2003009877A1 (en) 2001-07-24 2002-07-23 Topical pharmaceutical formulation

Publications (3)

Publication Number Publication Date
BR0211282A true BR0211282A (pt) 2004-08-03
BR0211282B1 BR0211282B1 (pt) 2018-01-09
BRPI0211282B8 BRPI0211282B8 (pt) 2021-05-25

Family

ID=23190223

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211282A BRPI0211282B8 (pt) 2001-07-24 2002-07-23 curativo compreendendo composição de fluido de silicone não volátil e seu método de manufatura, uso de composição para tratamento de cicatriz e de infecção por patógeno, bem como aplicador

Country Status (21)

Country Link
US (1) US8263114B2 (pt)
EP (1) EP1409034B1 (pt)
JP (1) JP3778559B2 (pt)
KR (1) KR101009267B1 (pt)
CN (1) CN1234426C (pt)
AT (1) ATE331537T1 (pt)
AU (1) AU2002317981B2 (pt)
BR (1) BRPI0211282B8 (pt)
CA (1) CA2454673C (pt)
DE (1) DE60212847T2 (pt)
DK (1) DK1409034T3 (pt)
ES (1) ES2268061T3 (pt)
HK (1) HK1061362A1 (pt)
IL (2) IL160109A0 (pt)
MX (1) MXPA04000444A (pt)
NO (1) NO334175B1 (pt)
NZ (1) NZ529957A (pt)
PT (1) PT1409034E (pt)
RU (1) RU2306121C2 (pt)
WO (1) WO2003009877A1 (pt)
ZA (1) ZA200400488B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
PT1648826T (pt) * 2003-07-03 2017-11-14 The Univ Court Of The Univ Of St Andrews Zeólitos para a administração de óxido nítrico
ES2407056T3 (es) * 2004-11-07 2013-06-11 Cupron Inc. Materiales que contienen cobre para tratar heridas, quemaduras y otras enfermedades de la piel
US20110046532A1 (en) * 2006-01-30 2011-02-24 Sanjeev Kaila composition including a silicone-based polymer and a method of treating skin disorders using the composition
MX2009014009A (es) * 2007-06-29 2010-05-20 Carmanah Technologies Corp Sistema de iluminacion de areas inteligente.
UA28103U (uk) * 2007-07-12 2007-11-26 Ольга Олександрівна Біляєва Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
US20100322875A1 (en) * 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
MX2012000827A (es) * 2009-07-17 2012-03-26 Carefusion 2200 Inc Particulas que incorporan agentes antimicrobianos.
RU2429820C2 (ru) * 2009-09-24 2011-09-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН") Антисептическая мазь наружного применения (2 варианта)
EP2496264A4 (en) * 2009-11-03 2014-03-26 Lipidor Ab COMPOSITION FOR PROMOTING WOUND HEALING
SI2496263T1 (sl) 2009-11-03 2022-05-31 Lipidor Ab Sestavek, ki tvori lipidni sloj, za dajanje na površino živega organizma
US10500173B2 (en) * 2010-06-17 2019-12-10 Covalon Technologies Inc. Antimicrobial silicone-based wound dressings
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
US20130144225A1 (en) 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) * 2016-12-22 2017-05-31 苏州迈达医疗器械有限公司 一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) * 2017-12-11 2018-12-10 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Спрей для наружного применения спиртовой
CN108714141A (zh) * 2018-05-29 2018-10-30 南京华开生物科技有限公司 硅酮疤痕喷剂
WO2020019050A1 (en) * 2018-07-26 2020-01-30 Exciton Pharma Corp. Vehicles and delivery systems for oxidizing agents
CA3115032A1 (en) * 2018-09-26 2020-04-02 Exaltexx Inc. Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en) 2019-03-28 2022-09-06 L'oreal Cosmetic compositions for skin
US11207255B2 (en) 2019-07-30 2021-12-28 L'oreal Perfluoro-free self-foaming facial cleanser composition
US11364190B2 (en) 2019-07-30 2022-06-21 L'oreal Acid perfluoro-free self-foaming facial cleanser composition
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618899B2 (ja) * 1987-06-30 1994-03-16 品川燃料株式会社 抗菌性ゼオライト含有フィルム
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja) 1990-04-04 1992-01-14 Kootec Kk 創傷被覆材
FR2678513B1 (fr) * 1991-07-03 1995-06-30 Laboratoires Hygiene Dietetique Pansement cicatrisant.
AU6525296A (en) 1995-07-19 1997-02-18 Innovative Technologies Limited Wound treatment composition
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja) 1996-01-19 1997-07-29 Morishita Jintan Kk 創傷被覆材
US6231259B1 (en) * 1996-07-26 2001-05-15 The Gillette Company Viscous product dispenser with porous dome
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
AU1923199A (en) * 1997-12-17 1999-07-05 Hemodynamics, Inc. Sealing media for surgery and wound closure
EP1152744B1 (en) 1999-02-12 2004-08-18 The Procter & Gamble Company Skin sanitizing compositions
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
GB0007140D0 (en) * 1999-09-27 2000-05-17 Dow Corning Sa Scar treatment composition
EP1286649A1 (en) 2000-05-23 2003-03-05 Unilever Plc Deodorant and/or antiperspirant compositions
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
MX2010003503A (es) * 2007-09-30 2010-04-21 Valeant Pharmaceuticals Int Composiciones basadas en gel de silicona para la curacion de heridas y reduccion de cicatrices.

Also Published As

Publication number Publication date
JP3778559B2 (ja) 2006-05-24
IL160109A0 (en) 2004-06-20
JP2005502639A (ja) 2005-01-27
MXPA04000444A (es) 2004-10-27
RU2004105164A (ru) 2005-06-27
US20040234474A1 (en) 2004-11-25
CA2454673C (en) 2011-04-26
AU2002317981B2 (en) 2006-12-07
ATE331537T1 (de) 2006-07-15
EP1409034A1 (en) 2004-04-21
US8263114B2 (en) 2012-09-11
CN1527729A (zh) 2004-09-08
NZ529957A (en) 2005-11-25
NO334175B1 (no) 2014-01-06
WO2003009877A1 (en) 2003-02-06
ZA200400488B (en) 2005-06-29
DE60212847T2 (de) 2007-06-14
ES2268061T3 (es) 2007-03-16
HK1061362A1 (en) 2004-09-17
BRPI0211282B8 (pt) 2021-05-25
RU2306121C2 (ru) 2007-09-20
PT1409034E (pt) 2006-11-30
EP1409034B1 (en) 2006-06-28
NO20040319L (no) 2004-01-23
DE60212847D1 (de) 2006-08-10
DK1409034T3 (da) 2006-10-30
CN1234426C (zh) 2006-01-04
KR20040032864A (ko) 2004-04-17
IL160109A (en) 2008-04-13
CA2454673A1 (en) 2003-02-06
KR101009267B1 (ko) 2011-01-18
BR0211282B1 (pt) 2018-01-09

Similar Documents

Publication Publication Date Title
BR0211282A (pt) Formulação farmacêutica
HK1076755A1 (en) Wound dressing
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
NO20024099L (no) Lavdose entecavir-formulering og anvendelse
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
NO20031407L (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
DE60104255D1 (de) Misch- und Zufuhrport für medizinische Anwendungen
HUP0300720A3 (en) Serine protease inhibitors, pharmaceutical compositions containing them and their use
AR027924A1 (es) Formulacion y sus usos
DK1330258T3 (da) Kahalalid F-formulering
NO20040254L (no) Farmasoytiske sammensetninger som inneholder terbinafin og anvendelse derav
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
DE60144265D1 (de) Halbleiterbauelement und dessen herstelllung
FR2833599B1 (fr) Polysaccharide amphotere, composition et utilisation
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
BR0213278B1 (pt) composição vedante e seu uso.
AR030853A1 (es) Composicion plaguicida
ATE450255T1 (de) Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung
HK1063469A1 (en) N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
PT1305314E (pt) Agente terapeutico cristalino
DE60230565D1 (de) Isolator und Isoliervorrichtung
DK1275383T3 (da) "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof
DE60234604D1 (de) Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoff
AU2001295301A1 (en) Medicinal composition and in particular its use in fluid therapy

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/07/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 23/07/2022